Prepare for tomorrow's life sciences industry landscape
Low-cost genomic sequencing and CRISPR genome editing technology are poised to shake up the life sciences industry and transform key points in the value chain. While the full ramifications will only reveal themselves in time, disruptions of the past provide a precedent for what to expect—and how established players can prepare to defend their competitive advantage.
Download our whitepaper to learn how to brace for disruption.